ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma acquires 40 million shares in eGenesis Inc
Natco Pharma's Canadian subsidiary has acquired 40 million shares in eGenesis Inc. for USD 8 million. eGenesis is a biotechnology company developing human-compatible organs for transplant through xenotransplantation. This investment aims to support eGenesi
Announcement as on 04 September 2024

Technical Breakout Stocks: PB Fintech up 90% in a year; Ajanta Pharma, Natco Pharma hit record highs
Indian markets rebounded on Wednesday after three days of declines, with the Sensex up nearly 900 points and Nifty50 rising over 300 points. Key sectors showing gains included PSU, energy, and metals.
Announcement as on 07 August 2024

USFDA pulls up Natco Pharma for several violations at Telangana plant
Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator. In the warning letter to the company, US Food and Drug Administration said its investigator
Announcement as on 21 April 2024

USFDA pulls up Natco Pharma for manufacturing lapses at Telangana plant
Natco Pharma's Telangana plant violated cleanliness and sterilisation standards at Kothur Village facility per USFDA. The warning letter mentioned cross-contamination, inadequate cleaning procedures, and the need for comprehensive investigations and correc
Announcement as on 21 April 2024

Complaint filed against Natco Pharma in US by Fresenius Kabi
Natco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled syringe. Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH filed the complaint against Natco Pharma USA LLC
Announcement as on 18 April 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 904.17
  • 12Day Average: 912.84
  • 20Day Average: 912.76
  • 50Day Average: 868.65
  • 100Day Average: 863.19
  • 150Day Average: 886.3
  • 200Day Average: 871.14

524816 Indicators & signals

Indicator MACD (12,26,9)

907.76, 898.75, 13.82
Indicator MACD is in positive zone

Indicator ADX (14)

9.76, 24.41, 20.06
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
31 Wed Dec 2025 903.55 898.55 to 908.00 0.72% 0.25 times
30 Tue Dec 2025 897.05 887.55 to 908.25 0.13% 0.94 times
29 Mon Dec 2025 895.90 894.20 to 911.30 -1.34% 0.51 times
26 Fri Dec 2025 908.10 905.70 to 920.00 -0.89% 0.86 times
24 Wed Dec 2025 916.25 911.50 to 926.70 -1.18% 1.07 times
23 Tue Dec 2025 927.15 922.50 to 950.40 0.38% 0.64 times
22 Mon Dec 2025 923.65 910.90 to 927.00 0.63% 1.12 times
19 Fri Dec 2025 917.90 913.10 to 943.00 0.33% 1.35 times
18 Thu Dec 2025 914.85 910.95 to 924.35 -0.83% 1.03 times
17 Wed Dec 2025 922.50 913.05 to 929.40 0.05% 1.18 times
16 Tue Dec 2025 922.05 904.45 to 928.00 1.87% 1.3 times
15 Mon Dec 2025 905.10 895.55 to 918.00 -0.11% 1.22 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top